ALENURA
Live / Registered — Registered (as of 15 Oct 2024)
What this means for you
Registered since 15 Oct 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90980073
- Registration number
- 7537930
- Mark type
- Stylized text
- Filed
- 01 Feb 2021
- Published for opposition
- 05 Oct 2021
- Registered
- 15 Oct 2024
- Attorney of record
- Joseph Agostino
Goods and services
- Class 044 — Medical, beauty and agricultural services: Providing information in the field of the diagnosis and treatment of urological ailments including interstitial cystitis and bladder pain syndrome (IC/BPS) via a website
Owner
- Urigen Pharmaceuticals Inc., Bound Brook, NJ, US
- Urigen Pharmaceuticals Inc., Bound Brook, NJ, US
- Urigen Pharmaceuticals Inc., Bound Brook, NJ, US
Prosecution history
- 15 Oct 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 15 Oct 2024 — REGISTERED-PRINCIPAL REGISTER
- 12 Sept 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 12 Sept 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 30 Jul 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 30 Jul 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 30 Jul 2024 — ASSIGNED TO LIE
- 09 Feb 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 08 Nov 2023 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 08 Nov 2023 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 10 Aug 2023 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 10 Aug 2023 — NON-FINAL ACTION E-MAILED
- 10 Aug 2023 — SU - NON-FINAL ACTION - WRITTEN
- 29 Jun 2023 — STATEMENT OF USE PROCESSING COMPLETE
- 30 May 2023 — USE AMENDMENT FILED